Rising popularity of injectable contraceptives in sub-Saharan Africa

Etude de la Population Africaine

Volumn 25, Issue 2, 2011, Pages 587-604

  Adetunji, Jacob A ^a  

^a UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884771164     PISSN: 08505780     EISSN: None     Source Type: Journal    
DOI: 10.11564/25-2-247     Document Type: Article

References (30)

1. Adetunji, JA. Preserving the pot and water: a traditional concept of reproductive health in a Yoruba community, Nigeria, Social Science and Medicine, Vol. 43, No. 11, pp. 1561-1567, 1996.
2. Aktun H, Moroy P, Cakmak P, Yalcun HR, and Mollamahmutoglu L. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women. Contraception, Vol. 72 (1):24-27, 2005.
3. Berenson AB and M Rahman, Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. American Journal of Obstetrics & Gynecology. Vol. 200, No. 3, pp. 329. e1-329. e8, 2009.
4. Biddlecom, AE and BM Fapohunda, Covert contraceptive use: prevalence, motivations and consequences, Studies in Family Planning, Vol. 29, No. 4, pp. 360-372, 1998.
5. nd edition, Atlanta GA: US Department of Health and Human Services, CDC, 1999.
6. Chrisman, CE KM Curtis, AP Mohllajee, ME Gaffield and HB Peterson, Effective use of hormonal contraceptives Part II: combined hormonal injectables, progestogenonly injectables and contraceptive implants, Contraception, 73 (2):125-133.
7. Cromer BA, Effects of hormonal contraceptives on bone mineral density. Drug Safety, Vol. 20(3):213-22, 1999.
8. Doyle, LL and WC Shields, Improving contraceptive technology: is it a zero-sum game? Contraception, Vol. 72, pp. 321-322, 2005
9. Glasier, A and WC Shields, Can we improve contraceptive use? Contraception, Vol. 73, pp. 1-3, 2006.
10. Gold MA, and Bachrach LK. Contraceptive use in teens: a threat to bone health? Journal of Adolescent Health, Vol.35:427-429, 2004.
11. Hatcher RA; Rinehart W; Blackburn R; Geller JS, The essentials of contraceptive technology: a handbook for clinic staff, Population Reports. Series J: Family Planning Programs. Vol. 44 (Suppl), 1997.
12. Hodes, R. Cross-cultural medicine and diverse health beliefs: Ethiopians abroad, The Western Journal of Medicine, Vol. 166, No. 1, pp. 29-36, 1997.
13. Lande, R. and C. Richey, Expanding Services for injectables, Population Reports, Series K, No. 6, INFO Project, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, 2006.
14. Lohiniva, A, M. Talaat, C. Bodenschatz, A. Kandeel, and M. El-Adawy, Therapeutic injections in the context of Egyptian culture, IUHPEPromotion and Education, Vol. 12, No. 1, pp. 13-18, 2005.
15. Magadi, M and SL Curtis, Trends and determinants of contraceptive method choice in Kenya, Studies in Family Planning, Vol. 34, No. 3, 149-159, 2003.
16. Mitchel MJ; Thistle P. Acceptability of levonorgestrel subdermal implants versus tubal ligation for long-term contraception in a rural population of Zimbabwe, Contraception, Vol. 70, pp. 483-486, 2004.
17. Ntozi PM and JB Kabera, Family Planning in Rural Uganda: Knowledge and Use of Modern and Traditional Methods in Ankole, Studies in Family Planning, Vol. 22, No. 2 (Mar.-Apr., 1991), pp. 116-123
18. Parr, NJ, Discontinuation of contraceptive use in Ghana, Journal of Health, Population and Nutrition, Vol 21, No. 2, pp. 150-157, 2003.
19. Petitti DB, Piaggio G, Mehta S, Cravioto MC and Meirik O. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. Obstetrics and Gynecology, Vol. 95(5):736-44, 2000.
20. Phillips, J and A, Bawah, Achieving success with community health services: the design, impact and utilization of the Navrongo Experiment in Ghana, unpublished paper presented at USAID, Washington DC, 2005.
21. Phillips, J, K. Adazu, M Adjuik and A. Nazzar, Denial of contraceptive use among known adopters in a rural area of northern Ghana, Unpublished paper presented at the annual meeting of the Population Association of America, March 27-39, 1997.
22. Rutenberg, N and S. Watkins, Conversation and contraception in Nyanza province, Kenya, Unpublished paper presented at the annual meeting of the Population Association of America, New Orleans, May 9-11, 1996.
23. Solo, Julie, R. Jacobstein, and D. Malema, Repositioning Family Planning-Malawi Case Study: Choice, Not Chance, New York: The ACQUIRE Project/Engenderhealth, September 2005.
24. Sullivan, TM, JT Bertrand, J. Rice and JD Shelton, Skewed contraceptive method mix: why it happens, why it matters, Journal of Biosocial Science, Col. 38, pp. 501-521, 2006.
25. Tanfer, K, S. Wierzbicki and B. Payn, Why are US women not using longacting contraceptives? Family Planning Perspectives, Vol. 32, No. 4, pp. 176-183&191, 2000.
26. Tolley, E, S. Loza, L. Kafafi, and S. Cummings, The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Egypt, International Family Planning Perspectives, Vol. 31, No. 1, pp. 15-23, 2005.
27. th ed., pp. 773-845, New York: Ardent Media, 2004.
28. United Nations, World Contraceptive Use 2011, UN Population Division, New York, 2011 (ST/ESA/SER. A/ 301).
29. World Health Organization (WHO), Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use. Third Edition. WHO, Geneva, Switzerland: 2004.
30. World Health Organization, Hormonal contraception and HIV: Science and Policy Africa Regional Meeting, Nairobi, 19-21 September 2005.